Thermophysiological and perceptual responses to exercise heat stress in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor

Abstract The objective of this study was to investigate thermophysiological and perceptual responses to exercise heat stress in people with cystic fibrosis (pwCF) on Elexacaftor/Tezacaftor/Ivacaftor (ETI) versus healthy controls, and to explore their lived experiences of heat stress. This mixed‐methods, multi‐study project comprised: (i) a laboratory study where pwCF ( n = 6) and matched controls ( n = 6) completed two 30 minutes cycling bouts in the heat (35°C, 30% relative humidity), at 150 and 250 W·m −2 metabolic heat production. Measures included sweat sodium chloride ([Na + Cl − ]), local and whole body sweat rate, deep body and skin temperatures, heart rate (HR), forearm and finger skin blood flow (SkBF), and perceptual responses (exertion, thermal sensation and comfort, thirst, heat‐illness symptom index (HISI)); and (ii) a pilot e‐survey ( n = 30) exploring free‐living sweating, heat experiences, hydration and salt‐supplementation practices. Laboratory data showed no significant differences in sweat [Na + Cl − ] (CON: 45 (36–106) mmol·L −1 ; pwCF: 75 (59–92) mmol·L −1 , P = 0.45), sweating rate, deep body and skin temperature, HR, SkBF, perceived exertion, thermal comfort, thermal sensation, or HISI ( P > 0.05). However, pwCF reported greater thirst at baseline ( P = 0.045) and after 30 minutes cycling ( P = 0.01), despite comparable hydration status. Survey responses indicated some pwCF perceive reduced sweating since starting ETI, yet their salt supplementation is unchanged. PwCF treated with ETI show thermophysiological/perceptual responses equivalent to healthy individuals during exercise heat stress. Together with survey insights, this suggests ETI may reduce previous heat‐related vulnerabilities and better prepare pwCF for exercise in hot conditions. Updated evidence is needed to refine salt‐replacement and hydration strategies, modernise clinical guidance, and support safe physical activity in a warming climate.

Authors

Institutions

Publication Details

Journal
Experimental Physiology
Published
2026-09-12
DOI
https://doi.org/10.1113/ep093605
Primary Topic
Thermoregulation and physiological responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

Thermophysiological and perceptual responses to exercise heat stress in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor

Zoe L. Saynor, Neil Maxwell, Anthony I. Shepherd, Jo Corbett et al.
Experimental Physiology
Thermoregulation and physiological responses
article

Thermophysiological and perceptual responses to exercise heat stress in people with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor

Zoe L. Saynor, Neil Maxwell, Anthony I. Shepherd, Jo Corbett, Heather Massey, Gary Connett, Don Urquhart, Thomas Daniels, Julian Legg, Mark Allenby, Lauren J. Clayton
article en

Abstract

Abstract The objective of this study was to investigate thermophysiological and perceptual responses to exercise heat stress in people with cystic fibrosis (pwCF) on Elexacaftor/Tezacaftor/Ivacaftor (ETI) versus healthy controls, and to explore their lived experiences of heat stress. This mixed‐methods, multi‐study project comprised: (i) a laboratory study where pwCF ( n = 6) and matched controls ( n = 6) completed two 30 minutes cycling bouts in the heat (35°C, 30% relative humidity), at 150 and 250 W·m −2 metabolic heat production. Measures included sweat sodium chloride ([Na + Cl − ]), local and whole body sweat rate, deep body and skin temperatures, heart rate (HR), forearm and finger skin blood flow (SkBF), and perceptual responses (exertion, thermal sensation and comfort, thirst, heat‐illness symptom index (HISI)); and (ii) a pilot e‐survey ( n = 30) exploring free‐living sweating, heat experiences, hydration and salt‐supplementation practices. Laboratory data showed no significant differences in sweat [Na + Cl − ] (CON: 45 (36–106) mmol·L −1 ; pwCF: 75 (59–92) mmol·L −1 , P = 0.45), sweating rate, deep body and skin temperature, HR, SkBF, perceived exertion, thermal comfort, thermal sensation, or HISI ( P > 0.05). However, pwCF reported greater thirst at baseline ( P = 0.045) and after 30 minutes cycling ( P = 0.01), despite comparable hydration status. Survey responses indicated some pwCF perceive reduced sweating since starting ETI, yet their salt supplementation is unchanged. PwCF treated with ETI show thermophysiological/perceptual responses equivalent to healthy individuals during exercise heat stress. Together with survey insights, this suggests ETI may reduce previous heat‐related vulnerabilities and better prepare pwCF for exercise in hot conditions. Updated evidence is needed to refine salt‐replacement and hydration strategies, modernise clinical guidance, and support safe physical activity in a warming climate.

Experimental Physiology
Royal Hospital for Children (GB), University Hospital Southampton NHS Foundation Trust (GB), National Institute for Health and Care Research (GB), NIHR Southampton Respiratory Biomedical Research Unit (GB), NIHR Southampton Biomedical Research Centre (GB), Children in Scotland (GB), University of Southampton (GB), University of Portsmouth (GB), University of Brighton (GB), University of Edinburgh (GB)
Openalex Percentile: Top 11%
Thermoregulation and physiological responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.